Literature DB >> 19800797

Late onset Rasmussen's encephalitis with triple pathology.

J Y Cheong1, C Wong, A Bleasel, W Varikatt, T Ng, M A Dexter.   

Abstract

Rasmussen's encephalitis is a devastating illness characterized by intractable focal seizures due to chronic localised encephalitis. We report on a rare variant of delayed onset Rasmussen's encephalitis with triple pathology. A 27-year-old male, who was initially diagnosed with seizures when he was 16 years old, presented with focal seizures that became refractory to multiple anticonvulsants. Multiple investigations, including subdural electrode monitoring, revealed foci of onset in the right frontotemporal region. The patient underwent right front-temporal lobectomy. Post-operatively, the seizures became more severe and he developed new epilepsia partialis continua. Treatment with intravenous immunoglobulin was unsuccessful. He subsequently underwent a right hemispherectomy that rendered him seizure free. The three pathologies identified were old ischemic changes, type II cortical dysplasia and stage II Rasmussen's encephalitis.

Entities:  

Mesh:

Year:  2009        PMID: 19800797     DOI: 10.1016/j.jocn.2009.02.042

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

1.  Epilepsy surgery in adult-onset Rasmussen's encephalitis: case series and review of the literature.

Authors:  Sara Casciato; Carlo Di Bonaventura; Anna Teresa Giallonardo; Jinane Fattouch; Pier Paolo Quarato; Addolorata Mascia; Alfredo D'Aniello; Andrea Romigi; Vincenzo Esposito; Giancarlo Di Gennaro
Journal:  Neurosurg Rev       Date:  2015-04-16       Impact factor: 3.042

Review 2.  Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review.

Authors:  Vijay M Ravindra; Marcus D Mazur; Carrie A Mohila; Matthew T Sweney; Aimee Hersh; Robert J Bollo
Journal:  Childs Nerv Syst       Date:  2015-06-02       Impact factor: 1.475

3.  Dual Pathology in Rasmussen's Encephalitis: A Report of Coexistent Focal Cortical Dysplasia and Review of the Literature.

Authors:  Richard A Prayson
Journal:  Case Rep Pathol       Date:  2012-09-29

4.  Bilateral Rasmussen's encephalitis associated with type II focal cortical dysplasia: Dormant 'second' epileptogenic zone in contralateral disease.

Authors:  Thomas Frigeri; Marta Hemb; Eliseu Paglioli; João Rubião Hoefel; Vinicius Silva; Harry Vinters; Andre Palmini
Journal:  Epilepsy Behav Case Rep       Date:  2013-04-27

5.  Rasmussen's encephalitis presenting as focal cortical dysplasia.

Authors:  D J O'Rourke; A Bergin; A Rotenberg; J Peters; M Gorman; A Poduri; J Cryan; H Lidov; J Madsen; C Harini
Journal:  Epilepsy Behav Case Rep       Date:  2014-03-12

6.  Triple Pathology in Rasmussen's Encephalitis: A New Pathological Phenotype.

Authors:  Ayush M Makkar; Snigdha Komakula; Ayush Agarwal; Saumya Sahu; Vaishali Suri; Achal K Srivasatava
Journal:  Ann Indian Acad Neurol       Date:  2022-02-14       Impact factor: 1.714

7.  International veterinary epilepsy task force recommendations for systematic sampling and processing of brains from epileptic dogs and cats.

Authors:  Kaspar Matiasek; Martí Pumarola I Batlle; Marco Rosati; Francisco Fernández-Flores; Andrea Fischer; Eva Wagner; Mette Berendt; Sofie F M Bhatti; Luisa De Risio; Robyn G Farquhar; Sam Long; Karen Muñana; Edward E Patterson; Akos Pakozdy; Jacques Penderis; Simon Platt; Michael Podell; Heidrun Potschka; Clare Rusbridge; Veronika M Stein; Andrea Tipold; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

8.  Triple pathology in patients with temporal lobe epilepsy: A case report and review of the literature.

Authors:  Kang Yang; Jing Su; Zengchun Hu; Rui Lang; Xu Sun; Xinyu Li; Dong Wang; Minghai Wei; Jian Yin
Journal:  Exp Ther Med       Date:  2013-07-19       Impact factor: 2.447

9.  A Case Series of Adult-Onset Rasmussen's Encephalitis: Diagnostic and Therapeutic Challenges.

Authors:  James Francis Castellano; Jenny A Meyer; Fred Alexander Lado
Journal:  Front Neurol       Date:  2017-10-25       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.